A meta-analysis of 3,619 deaths among individuals with diabetes and those who also had a history of foot ulcers reported a high risk of mortality from any cause in those patients who had diabetic foot ulcers; relative risk was 1.89.
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that consuming whey protein before a regular breakfast reduces the blood sugar spikes seen after meals and also improves the body’s insulin response.
This week, Wil explores that always-tough issue of weight gain when it comes to diabetes and how food isn’t always the culprit.
Afrezza is a rapid-acting inhaled insulin to be administered prior to meals or within 20 minutes of starting a meal. It is not a substitute for long-acting insulin and must be used in combination with long-acting insulin in patients with type 1 diabetes. It is not recommended for the treatment of diabetic ketoacidosis or in […]
Among the many nutrition supplements trumpeted for potential health benefits, fish oil supplements have been among the most ballyhooed. But as the research on fish oil rolls in, it’s unclear whether the supplements provide all the touted benefits, or are as harmless as claimed.
A new inhaled insulin is finally approved! When is predictive low glucose suspend coming? Plus, the launch of a new meter and more!
Heather reviews TruePlus glucose products, a line of products from Nipro Diagnostics that includes a flavorful variety of glucose tabs, gel, and liquid “shots”.
A recent study in the journal Hepatology found that 27 percent of kids’ diets come from high-fat, high-sugar snacks, and the frequent grazing is directly linked to belly fat accumulation. Fortunately, there’s also research to suggest we can snack smartly — and slim down. Here are six tips that will help you Eat It to […]
his month, we attended the 74th annual Scientific Sessions of the American Diabetes Association, the largest diabetes conferences of the year. Lucky for us, it was held in our hometown of San Francisco. The conference featured updates on major progress with the artificial pancreas, a new and exciting (and a bit daunting) position statement for […]
Researchers at Brown University may have developed a new sensor that would allow the sampling of saliva for glucose testing. The sensor relies on plasmonic interferometry, a light-based way of detecting chemical compounds, and a dual-enzyme assay that works as a dye, to mark glucose.
A systematic review and meta-analysis of available data published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that combined aerobic and resistance training, rather than either alone, is best for controlling both blood sugar and blood fat profiles among people with type 2 diabetes.
A recently completed study that compared two types of insulin for treating inadequately controlled type 2 patients showed that insulin degludec/insulin aspart produced fewer instances of hypoglycemia than biphasic insulin aspart 30.
The authors from the CDC add that “chronic diseases are the main causes of poor health, disability, and death, and account for most of health care expenditures” in the US.
Depression was a big topic at the ADA’s Scientific Sessions last month. It might be an issue for you, too. Why so much attention? Depression is three to four times more common in people with diabetes than in those without, depending on the study and the country.
Claresa Levetan, M.D., is a noted endocrinologist with expertise spanning diverse areas of diabetes. She has been internationally recognized for the translation of science and technology into improved health care options for patients with diabetes. In this article, Dr. Claresa explains her life journey on developing better technology for diabetes management.
The study found that almonds can keep blood vessels healthy by increasing the amount of antioxidants in the blood stream, lowering blood pressure and improving blood flow.
We in the diabetes community are no strangers to this technology, or the key researchers behind it, D-Dad Ed Damiano and his partner Dr. Steven Russell. But the trial results they presented at the recent ADA conference have catapulted this into the public eye, for better or worse
The team from Columbia University Medical Center in New York City said their findings hold promise for the development of a new treatment for type 1 diabetes that does not involve stem cells.
A recent study in JAMA Internal Medicine, by researchers at the Department of Veterans Affairs, notes that among adults aged 65 and older, insulin and sulfonylurea drugs are “the second most common medications associated with emergency department visits or hospitalizations and adverse drug events.” That’s just the tip of the iceberg, experts believe.
For patients with type 2 diabetes – especially those over age 50 – the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs, says a new study by the University of Michigan Health System, the VA Ann Arbor Healthcare System, and University College London.